128 related articles for article (PubMed ID: 25906121)
1. Differentiating Small Cell Carcinoma From Squamous Cell Carcinoma in Cytologic Specimens: A Head-to-Head Comparison of p40 and p63 Using Cell Block Immunocytochemistry.
Gailey MP; Bellizzi AM; Jensen CS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):11-5. PubMed ID: 25906121
[TBL] [Abstract][Full Text] [Related]
2. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
Vogt AP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
[TBL] [Abstract][Full Text] [Related]
3. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non-Small Cell Carcinoma?
Alexander M; Chiaffarano J; Zhou F; Cangiarella J; Yee-Chang M; Simsir A
Am J Clin Pathol; 2017 Jun; 147(6):580-588. PubMed ID: 28498881
[TBL] [Abstract][Full Text] [Related]
4. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
5. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
van Zyl A; Schubert PT; Koegelenberg CFN
Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
[TBL] [Abstract][Full Text] [Related]
6. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy.
Collins BT; Wang JF; Bernadt CT
Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322
[TBL] [Abstract][Full Text] [Related]
7. Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.
Jain D; Mathur SR; Guleria R; Iyer VK
Cytopathology; 2014 Oct; 25(5):330-5. PubMed ID: 24128123
[TBL] [Abstract][Full Text] [Related]
8. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
Fatima N; Cohen C; Lawson D; Siddiqui MT
Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
[TBL] [Abstract][Full Text] [Related]
9. Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut.
Bakhshwin AM; Gordon IO; Brown KB; Liu X; Allende DS
Int J Surg Pathol; 2020 Dec; 28(8):835-843. PubMed ID: 32466705
[TBL] [Abstract][Full Text] [Related]
10. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
11. [Expression of p63, p40 and CK5/6 in small cell lung cancer].
Zhang L; Hou L; Xie H; Dong Z; Wu W; Kong J; Chen G; Wu C
Zhonghua Bing Li Xue Za Zhi; 2015 Sep; 44(9):644-7. PubMed ID: 26705280
[TBL] [Abstract][Full Text] [Related]
12. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
[TBL] [Abstract][Full Text] [Related]
13. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
[TBL] [Abstract][Full Text] [Related]
14. p40 (ΔNp63) and keratin 34βE12 provide greater diagnostic accuracy than p63 in the evaluation of small cell lung carcinoma in small biopsy samples.
Butnor KJ; Burchette JL
Hum Pathol; 2013 Aug; 44(8):1479-86. PubMed ID: 23528865
[TBL] [Abstract][Full Text] [Related]
15. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M
Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982
[TBL] [Abstract][Full Text] [Related]
16. p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, cytokeratin 5/6, desmocollin-3, and sox2.
Tatsumori T; Tsuta K; Masai K; Kinno T; Taniyama T; Yoshida A; Suzuki K; Tsuda H
Appl Immunohistochem Mol Morphol; 2014; 22(5):377-82. PubMed ID: 24805133
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
[TBL] [Abstract][Full Text] [Related]
18. [Cytology of basaloid squamous cell carcinoma and small cell carcinoma of lung: a comparative study].
He SR; Bai YP; Gong H; Di J; Chen L; Dai WD; Hu ST; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):237-42. PubMed ID: 27033386
[TBL] [Abstract][Full Text] [Related]
19. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
Kim MJ; Shin HC; Shin KC; Ro JY
Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
[TBL] [Abstract][Full Text] [Related]
20. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]